Moreover, the protocol developed required either the use of conditioned medium obtained from the B104 rat neuroblastoma cell line or the overexpression of the pro-oligodendrocyte Olig-2 gene delivered by lentiviral transduction, further raising difficulties for possible future therapeutic applications. Here, OLIG2 is linked to neuroblastoma.